| Date |
Research Question / Title |
Unique ID |
Research Team |
|
March 29, 2021
|
What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC?
|
LTC012501 RR
|
Long Term Care
|
|
March 8, 2021
|
What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC?
|
LTC012501v2-01 ESR
|
Long Term Care
|
|
February 26, 2021
|
What are the efficacies and outcomes of Point-of-Care/Antigen testing in Long Term care?
|
LTC020201 RR
|
Long Term Care
|
|
February 5, 2021
|
What are the efficacies and outcomes of Point-of-Care/Antigen testing in Long Term care?
|
LTC020201-01 ESR
|
Long Term Care
|
|
December 18, 2020
|
What is the risk of COVID-19 transmission during AGMP procedures?
|
PPE120901 RR
|
Personal Protective Equipment
|
|
December 13, 2020
|
What is the evidence for a 14 day isolation period upon move-in to a continuing care environment during the COVID-19 pandemic?
|
LTC090801 RR
|
Long Term Care
|
|
December 11, 2020
|
What is the risk of COVID-19 transmission during AGMP procedures?
|
PPE120901-01 ESR
|
Personal Protective Equipment
|
|
October 2, 2020
|
What is the evidence for a 14 day isolation period upon move-in to a continuing care environment during the COVID-19 pandemic?
|
LTC090801-01 ESR
|
Long Term Care
|
|
April 29, 2020
|
How can LTC facilities prepare for a pandemic?
|
LTC042201 RR
|
Long Term Care
|
|
April 28, 2020
|
What characteristics of residents in LTC homes affect the ability to provide routine care during a COVID-19 or ILI outbreak?
|
LTC042201-03 ESR
|
Long Term Care
|
|
April 25, 2020
|
What environmental management and built environment factors influence a home’s ability to prevent or manage an ILI outbreak? AND
What is the evidence for infection control practices (checklist items) for preventing or managing an ILI outbreak?
|
LTC042201-02 ESR
|
Long Term Care
|
|
24-Apr-2020
|
How can LTC facilities prepare for a pandemic?
|
LTC042201-01 ESR
|
Long Term Care
|
|
April 1, 2020
|
What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments?
|
EOC040101-01 ESR
|
EOC
|
|
April 1, 2020
|
What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments?
|
EOC040101 RR
|
EOC
|
|
March 30, 2020
|
Where and how are they producing and using intubation hoods?
|
EOC033001-01 ESR
|
EOC
|
|
March 30, 2020
|
Where and how are they producing and using intubation hoods?
|
EOC033001 RR
|
EOC
|
